Biological actions and therapeutic potential of the glucagon-like peptides

This publication has 114 references indexed in Scilit:

• Colocalization of Glucagon‐Like Peptide‐1 (GLP‐1) Receptors, Glucose Transporter GLUT‐2, and Glucokinase mRNAs in Rat Hypothalamic Cells: Evidence for a Role of GLP‐1 Receptor Agonists as an Inhibitory Signal for Food and Water Intake
  Journal of Neurochemistry, 1996
• Short‐Chain Fatty Acids Increase Proglucagon and Ornithine Decarboxylase Messenger RNAs After Intestinal Resection in Rats
  Journal of Parenteral and Enteral Nutrition, 1996
• Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function
  European Journal of Pharmacology: Molecular Pharmacology, 1995
• Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum
  European Journal of Biochemistry, 1993
• Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
  Digestive Diseases and Sciences, 1993
• Identical mRNA for preproglucagon in pancreas and gut
  European Journal of Biochemistry, 1987
• Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
  Journal of Clinical Investigation, 1987
• Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut
  FEBS Letters, 1987
• Glucagonoma syndrome demonstrating giant duodenal villi.
  Gut, 1984
• Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities
  Peptides, 1981